相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
Diptaman Chatterjee et al.
GENE THERAPY (2022)
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression
Barbara A. Konkle et al.
BLOOD (2021)
The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
Francoise Piguet et al.
HUMAN GENE THERAPY (2021)
Deep diversification of an AAV capsid protein by machine learning
Drew H. Bryant et al.
NATURE BIOTECHNOLOGY (2021)
Gene-based therapies for neurodegenerative diseases
Jichao Sun et al.
NATURE NEUROSCIENCE (2021)
Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia
Carmen Gasca-Salas et al.
NATURE COMMUNICATIONS (2021)
Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries
Andrew D. Marques et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning
Mathieu Nonnenmacher et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives
Gayathri R. Ediriweera et al.
MOLECULAR PHARMACEUTICS (2021)
A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease
Gerhard Leinenga et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy
Jerry R. Mendell et al.
JAMA NEUROLOGY (2021)
Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning
Anna Z. Wec et al.
FRONTIERS IN IMMUNOLOGY (2021)
Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy
Grace Elizabeth Mulia et al.
HUMAN GENE THERAPY (2021)
The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions
Jack C. de la Torre et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels
Raleigh M. Linville et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors
Visish M. Srinivasan et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2020)
A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna
Toloo Taghian et al.
MOLECULAR THERAPY (2020)
Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex
Chengyan Chu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Colin K. W. Lim et al.
MOLECULAR THERAPY (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases
Barbara A. Perez et al.
BRAIN SCIENCES (2020)
Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound
Ali R. Rezai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy
Sea Young Yoon et al.
BRAIN (2020)
Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies
Rachel M. Bailey et al.
BRAIN RESEARCH (2020)
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
Juliette Hordeaux et al.
HUMAN GENE THERAPY (2020)
A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis
Christian Hinderer et al.
HUMAN GENE THERAPY (2020)
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
Diana Alarcon-Aris et al.
EBIOMEDICINE (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound
Mihaela Stavarache et al.
JOURNAL OF NEUROSURGERY (2019)
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
Juliette Hordeaux et al.
MOLECULAR THERAPY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Eloise Hudry et al.
NEURON (2019)
Adeno-Associated Virus (AAV) Versus Immune Response
Joseph Rabinowitz et al.
VIRUSES-BASEL (2019)
Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase RescuesBoth Muscle and CNS Defects in Murine Pompe Disease
Jeong-A Lim et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
Hildegard Buning et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease
Peter A. LeWitt et al.
MOVEMENT DISORDERS (2019)
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta M. Riboldi et al.
CELLS (2019)
Onasemnogene Abeparvovec: First Global Approval
Sheridan M. Hoy
DRUGS (2019)
In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound: [18F]DPA-714 PET study
Sanhita Sinharay et al.
JOURNAL OF NEUROINFLAMMATION (2019)
The Emerging Role of microRNAs in Polyglutamine Diseases
Xiaoyu Dong et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Gene Therapy Tools for Brain Diseases
Selene Ingusci et al.
FRONTIERS IN PHARMACOLOGY (2019)
Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
Cia-Hin Lau et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Allison M. Keeler et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
Kousaku Ohno et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Molecular pathology of neurodegenerative diseases: principles and practice
Gabor G. Kovacs
JOURNAL OF CLINICAL PATHOLOGY (2019)
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice
William A. Liguore et al.
MOLECULAR THERAPY (2019)
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids
Qin Huang et al.
PLOS ONE (2019)
First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
Agessandro Abrahao et al.
NATURE COMMUNICATIONS (2019)
Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation
Leila Haery et al.
FRONTIERS IN NEUROANATOMY (2019)
Context-dependency of synthetic minimal promoters in driving gene expression: a case study
Liyuan Jin et al.
MICROBIAL BIOTECHNOLOGY (2019)
Gene therapy for lysosomal storage diseases and peroxisomal diseases
Toya Ohashi
JOURNAL OF HUMAN GENETICS (2019)
Gene Therapy for Neurodegenerative Diseases
Vivek Sudhakar et al.
NEUROTHERAPEUTICS (2019)
Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer's disease
Bradford M. Elmer et al.
PLOS ONE (2019)
Neurointerventional Radiology for the Aspiring Radiology Resident: Current State of the Field and Future Directions
Mougnyan Cox et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Selection of an Efficient AAV Vector for Robust CNS Transgene Expression
Killian S. Hanlon et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
Raygene Martier et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Overcoming the Blood-Brain Barrier. Challenges and Tricks for CNS Drug Delivery
Luca Anna Bors et al.
SCIENTIA PHARMACEUTICA (2019)
Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note
Michal Zawadzki et al.
BMJ CASE REPORTS (2019)
Focused ultrasound with microbubbles induces sterile inflammatory response proportional to the blood brain barrier opening: Attention to experimental conditions
Zsofia I. Kovacs et al.
THERANOSTICS (2018)
Viral Strategies for Targeting the Central and Peripheral Nervous Systems
Claire N. Bedbrook et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B
Robert D. Dayton et al.
GENE THERAPY (2018)
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
Christian Hinderer et al.
HUMAN GENE THERAPY (2018)
Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals
Christian Hinderer et al.
HUMAN GENE THERAPY (2018)
Recent progress and considerations for AAV gene therapies targeting the central nervous system
Erik Allen Lykken et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2018)
Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis
Andrew E. Arrant et al.
JOURNAL OF NEUROSCIENCE (2018)
Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy
Michael S. Marshall et al.
MOLECULAR THERAPY (2018)
Gene Therapy Strategies to Restore ER Proteostasis in Disease
Vicente Valenzuela et al.
MOLECULAR THERAPY (2018)
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Juliette Hordeaux et al.
MOLECULAR THERAPY (2018)
Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain
Yasunori Matsuzaki et al.
NEUROSCIENCE LETTERS (2018)
Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
Peijian Yue et al.
FRONTIERS IN NEUROSCIENCE (2018)
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Jonathan B. Rosenberg et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
Zachary Fitzpatrick et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
Juliette Hordeaux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Noninvasive delivery of an α-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound
Kristiana Xhima et al.
MOVEMENT DISORDERS (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain
Zsofia I. Kovacs et al.
THERANOSTICS (2018)
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
Stephane Palfi et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
Real-Time MRI Guidance for Reproducible Hyperosmolar Opening of the Blood-Brain Barrier in Mice
Chengyan Chu et al.
FRONTIERS IN NEUROLOGY (2018)
The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2
Danielle Weber-Adrian et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Gene-editing therapy for neurological disease
Moira A. McMahon et al.
NATURE REVIEWS NEUROLOGY (2017)
Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation
Zsofia I. Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin et al.
EXPERIMENTAL NEUROLOGY (2017)
Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders
K. Bey et al.
GENE THERAPY (2017)
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
Su Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Ultrasound targeted CNS gene delivery for Parkinson's disease treatment
Ching-Hsiang Fan et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy
Giuseppe Morabito et al.
MOLECULAR THERAPY (2017)
Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model
Brian P. Mead et al.
NANO LETTERS (2017)
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
Paul S. Fishman et al.
NEUROTHERAPEUTICS (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
In silico design of context-responsive mammalian promoters with user-defined functionality
Adam J. Brown et al.
NUCLEIC ACIDS RESEARCH (2017)
Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose
Dallan McMahon et al.
THERANOSTICS (2017)
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
Federico Mingozzi et al.
ANNUAL REVIEW OF VIROLOGY, VOL 4 (2017)
Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain Barrier
Wei-Bin Shen et al.
CELL TRANSPLANTATION (2017)
Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease
Margaret M. P. Pearce
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model
Rebecca M. Nisbet et al.
BRAIN (2017)
Predicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidance
Miroslaw Janowski et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
David S. Hersh et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Michael Hocquemiller et al.
HUMAN GENE THERAPY (2016)
Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
Joana Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector
Sourav R. Choudhury et al.
MOLECULAR THERAPY (2016)
Genome-editing Technologies for Gene and Cell Therapy
Morgan L. Maeder et al.
MOLECULAR THERAPY (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
Role of FET proteins in neurodegenerative disorders
Francesca Svetoni et al.
RNA BIOLOGY (2016)
Advances in therapeutic CRISPR/Cas9 genome editing
Natasa Savic et al.
TRANSLATIONAL RESEARCH (2016)
Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease
Ching-Hsiang Fan et al.
SCIENTIFIC REPORTS (2016)
Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY METHODS (2016)
Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B
Kasey L. Jackson et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
Gabor G. Kovacs
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Intraarterial drug delivery for glioblastoma mutiforme
Shailendra Joshi et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose-response Study in Mice and Nonhuman Primates
Kathrin Meyer et al.
MOLECULAR THERAPY (2015)
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Emma L. Scotter et al.
NEUROTHERAPEUTICS (2015)
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model
Gerhard Leinenga et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
Yannick Tanguy et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
Clinical Presentation, Imaging, and Management of Complications due to Neurointerventional Procedures
Matthew C. Davis et al.
SEMINARS IN INTERVENTIONAL RADIOLOGY (2015)
Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus
S. Wang et al.
GENE THERAPY (2015)
Synthetic biology and therapeutic strategies for the degenerating brain Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases
Carmen Agustin-Pavon et al.
BIOESSAYS (2014)
Intracisternal delivery of AAV9 results in oligodendrocyte and Motor neuron transduction in the whole central nervous system of cats
T. Bucher et al.
GENE THERAPY (2014)
Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
Marc Tardieu et al.
HUMAN GENE THERAPY (2014)
Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption
Conor P. Foley et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood - brain barrier using MRI-guided focused ultrasound
Elizabeth Nance et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10
Bin Yang et al.
MOLECULAR THERAPY (2014)
AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction
Lluis Samaranch et al.
MOLECULAR THERAPY (2014)
Intrathecal Gene Therapy Corrects CNS Pathology in a Feline Model of Mucopolysaccharidosis I
Christian Hinderer et al.
MOLECULAR THERAPY (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CRISPR interference (CRISPRi) for sequence-specific control of gene expression
Matthew H. Larson et al.
NATURE PROTOCOLS (2013)
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
Raymond T. Bartus et al.
NEUROLOGY (2013)
Activation of the Cellular Unfolded Protein Response by Recombinant Adeno-Associated Virus Vectors
Balaji Balakrishnan et al.
PLOS ONE (2013)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
The dappled nature of causes of psychiatric illness: replacing the organic-functional/hardware-software dichotomy with empirically based pluralism
K. S. Kendler
MOLECULAR PSYCHIATRY (2012)
Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery
Brooke R. Snyder et al.
HUMAN GENE THERAPY (2011)
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A. LeWitt et al.
LANCET NEUROLOGY (2011)
Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
Nagesh Pulicherla et al.
MOLECULAR THERAPY (2011)
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
William J. Marks et al.
LANCET NEUROLOGY (2010)
Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma A Technical Note
H. A. Riina et al.
INTERVENTIONAL NEURORADIOLOGY (2010)
Advances in high-capacity extrachromosomal vector technology: Episomal maintenance, vector delivery, and transgene expression
Michele M. P. Lufino et al.
MOLECULAR THERAPY (2008)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
Gene therapy for severe combined immunodeficiency: are we there yet?
Marina Cavazzana-Calvo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Enhanced prospects for drug delivery and brain targeting by the choroid Plexus-CSF route
CE Johanson et al.
PHARMACEUTICAL RESEARCH (2005)
Evaluation of tumor-specific promoter activities in melanoma
B Lu et al.
GENE THERAPY (2005)
Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications
K Hynynen et al.
NEUROIMAGE (2005)
Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV
LM Sanftner et al.
MOLECULAR THERAPY (2004)
Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles
N Sheikov et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2004)
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
N Bessis et al.
GENE THERAPY (2004)
Therapeutic goals in the treatment of Gaucher disease
GM Pastores et al.
SEMINARS IN HEMATOLOGY (2004)
Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors
T Abe et al.
CANCER GENE THERAPY (2002)
分享论文
